PET-FDG: Impetus
Open Access
Abstract
The International Myeloma Working Group (IMWG)recommends FDG PET/CT (Fluoro-Deoxy-glucose Positron Emission Tomography/Computed Tomography) as the gold standard imaging modality for initial evaluation and response to therapy assessment in multiple myeloma. In fact, FDG PET/CT, provides multiple useful indexes to risk-stratify patients and has significant prognostic value. However, multiple myeloma remains a complex disease to interpret on imaging. The Italian myeloma criteria for PET use (IMPeTUs) were proposed to standardize FDG PET/CT reading in multiple myeloma. In this communication an overview on IMPeTUs is provided as well as some examples of application.Keywords
This publication has 12 references indexed in Scilit:
- Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- The Role of18F-FDG PET/CT in Multiple Myeloma Staging according to IMPeTUs: Comparison of the Durie–Salmon Plus and Other Staging SystemsContrast Media & Molecular Imaging, 2018
- Pathogenesis of bone disease in multiple myeloma: from bench to bedsideBlood Cancer Journal, 2018
- Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)European Journal of Nuclear Medicine and Molecular Imaging, 2017
- Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myelomaBlood, 2017
- Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)European Journal of Nuclear Medicine and Molecular Imaging, 2015
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- When should FDG‐PET be used in the modern management of lymphoma?British Journal of Haematology, 2013
- Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple MyelomaJournal of Nuclear Medicine, 2012
- Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working GroupJournal of Clinical Oncology, 2010